Demant gets FDA green light for new bone-anchored hearing solution
Oticon Medical, Demant's implants arm, has had its new bone-anchored product, Ponto 5 Superpower, cleared in the US. Following the FDA approval, the device is expected to be on shelves in spring.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
The US Food and Drug Administration (FDA) has cleared Oticon Medical, Demant's implants arm, to market and sell its newest bone anchored hearing system (BAHS), a company press release announces.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Oticon: Covid-19 led to debates about product launches
For subscribers
